Replies to post #69421 on Biotech Values

[DewDiligence]

>evotec was public on the frankfurt exchange. They listed on Nasdaq by merging with Renovis…<

That’s right—I should have said that the reverse merger enabled EVTC to become publicly traded on a US exchange.

>[EVTC] paid a premium to [Renovis’] cash. The reverse mergers usually discount the cash.<

Some reverse mergers go off at a discount to net cash, but I’m not sure I agree that this is the norm.